YAP1 and heart failure: Sustained YAP1 activation in CMs with cell-cycle re-entry, increased de-differentiation, and decreased apoptosis; cardiac dysfunction, severe heart failure, and enhanced mortality in response to TAC (Ikeda et al., 2019a, b)